Home KBL Solutions US Patent 6630507 – What You Need to Know

US Patent 6630507 – What You Need to Know

US Patent 6630507 – What You Need to Know

While the DEA, Attorney General Jeff Sessions, and Department of Justice fight to keep marijuana a Schedule I drug (the same category as heroin and PCP) claiming it has no medical value; the US Department of Health and Human Services clearly has a different opinion, as it owns US Patent 6630507, for the medicinally therapeutic properties of the plant.

Fourteen years ago, this month, the US government issued a patent for cannabis-based compounds to itself, yet cannabis patients, caregivers, and advocates are still fighting to prove the healing properties of the herb.

The patent clearly states that cannabinoids are powerful antioxidants which have the potential to treat a myriad of ischemic, age-related, inflammatory, and auto-immune disorders. The patent goes on to say cannabinoids are also a natural neuroprotectant which could help treat neurological damage caused by stroke and trauma, as well as, other neurological disorders like Alzheimer’s, Parkinson’s Disease, and Multiple Sclerosis.

Due to this definition of cannabinoids having known medical and therapeutic effects by the US Government, the number 6630507 went viral on the internet as cannabis users and supporters from all over the world told the DEA to “talk to the hand”, as they wrote “#6630507” on their hands and anything else marijuana-related and posted them to social media.


Comments Bellow